Exelan

Cipla Buys Two U.S. Pharma Firms for $550M
Strategy

Cipla Buys Two U.S. Pharma Firms for $550M

The acquisitions give the Indian drug maker its first manufacturing plant in the U.S. and an opportunity to build U.S. market share.
By Katie Kuehner-Hebert | September 4, 2015
Read More